CD33/CD123-targeted CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD33/CD123-targeted CAR-T cells, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML [Phase 1, Phase 2]